About Us
Crafted with Passion.
Our Cannabis Processor.
Our Cannabis Processor.
The leading purveyor of regional products for cannabis enthusiasts.
Our Cannabis Processor.
Our Cannabis Processor.
Our Cannabis Processor.
Your Cannabis Vision is our Mission.
Forwarding information to Emerald Health and Skye Bioscience
On November 10, 2022, Emerald Health Therapeutics, Inc. was acquired by Skye Bioscience, Inc. (OTCQB:SKYE), a San Diego-based pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet needs. Skye is currently conducting Phase 1 clinical trial for its lead candidate SBI-100 Ophthalmic Emulsion and expects to initiate its Phase 2 study shortly. We are also conducting research to expand our pipeline of potential drug candidates.
Learn about Skye by exploring its website and staying up-to-date via its corporate newsletter and social channels. Follow the links below:
